• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Antibacterial Peptide Spray Safe for Use on Wounds

      Antibacterial Peptide Spray Safe for Use on Wounds

      Flexible Sensors Detect Heavy Metals in Sweat

      Flexible Sensors Detect Heavy Metals in Sweat

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

    • Radiology
      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

    • Cardiology
      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

    • Surgery
      Antibacterial Peptide Spray Safe for Use on Wounds

      Antibacterial Peptide Spray Safe for Use on Wounds

      Microneedle Bandage for Hemostatic Control

      Microneedle Bandage for Hemostatic Control

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Epilepsy Pipeline Analysis: 70+ Key Pipeline Therapies and 70+ Key Pharma Players are Looking Out in the Epilepsy Pipeline Landscape

August 4th, 2022 DelveInsight Business Research Releases

DelveInsight’s ‘Epilepsy Pipeline Insight 2022‘ report provides comprehensive global coverage of available, marketed, and pipeline epilepsy therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the epilepsy pipeline domain.

For epilepsy emerging drugs, the Epilepsy pipeline analysis report provides a 360° view of the therapeutics landscape by development point, product type, route of administration, molecule type, and MOA. The pipeline research covers business opportunities, challenges, future partnerships, strong competitors, and growth strategies.

Some of the Key Highlights from Epilepsy Pipeline Report

  • Over 70+ epilepsy pipeline therapies are in various stages of growth, and their anticipated acceptance in the epilepsy market would significantly increase market revenue.
  • Leading epilepsy companies such as Eisai Co.LTD., Alexza Pharmaceuticals, Xenon Pharmaceuticals, GW Pharmaceuticals, Equilibre Biopharmaceuticals, Takeda Pharmaceuticals, Abide therapeutics, Otsuka pharmaceutical, CombiGene, and others are evaluating novel epilepsy treatment drugs candidate to improve the treatment landscape.
  • Key epilepsy pipeline therapies in various stages of development include Perampanel, Alprazolam, XEN1101, GWP42006, EQU-001, TAK-935, Lu AG06466, OPC-214870, CG 01, and others.
  • Out of the emerging epilepsy therapies, XEN1101 is in the late stage of development, whereas Lu AG06466 is in the early stage of development. 
  • CombiGene is currently evaluating CG 01 in the preclinical stage. 

Request a sample and discover the recent advances in epilepsy therapies @ Epilepsy Pipeline Insight and Outlook

Epilepsy Overview

Epilepsy is a pretty common neurological disease affecting people worldwide. It affects roughly 3 million people in the United States. Epilepsy can affect anyone, but it is more frequent in children and elderly adults. It affects males slightly more than females. Epilepsy symptoms vary depending on the region of the brain where seizure activity occurs and the type of seizure. Epilepsy treatment can help most people with epilepsy have fewer seizures or totally stop experiencing seizures. The epilepsy causes are unknown In nearly half of those who have epilepsy. The specialist may recommend an electroencephalogram (EEG) test for epilepsy diagnosis to monitor the brain activity or a brain scan to look for any problems in the brain.

For more information about epilepsy drugs, visit: Epilepsy Treatment Drugs

Epilepsy Pipeline Analysis: Drug Profile

XEN1101:Xenon Pharmaceuticals

Xenon 1101, a novel KV7 potassium channel opener, is being developed for the treatment of epilepsy. Ezogabine, an earlier generation Kv7 opener licenced by the FDA as an additional treatment for individuals with focal seizures with or without secondary generalisation, clinically verified the Kv7 potassium channel mechanism.

TAK-935:Takeda Pharmaceuticals

Soticlestat is a first-in-class, potent, highly selective inhibitor of the enzyme cholesterol 24-hydroxylase (CH24H) with the potential to reduce seizure susceptibility and enhance seizure control. CH24H is found primarily in the brain, where it converts cholesterol into 24S-hydroxycholesterol (24HC) to maintain the homeostatic equilibrium of brain cholesterol. 24HC is a positive allosteric modulator of the NMDA receptor that affects glutamatergic signalling in epilepsy.

Gain more knowledge on emerging epilepsy drugs @ Novel Epilepsy Drugs

Pipeline Therapies and Key Companies

  • XEN496: Xenon Pharmaceuticals
  • AMZ002: Amzell
  • XEN1101: Xenon Pharmaceuticals
  • EQU 001: Equilibre Biopharmaceuticals
  • Lu AG06466: Lundbeck
  • OPC-214870: Otsuka Pharmaceutical
  • CG 01: CombiGene

Learn more about the FDA approved epilepsy therapies @ Epilepsy Clinical Trials

Epilepsy Pipeline Therapeutics Assessment

By Product Type

  • Monotherapy
  • Combination Therapy

By Stage

  • Discovery
  • Pre-Clinical
  • Phase I
  • Phase II
  • Phase III
  • Pre-registration

By Route of Administration

  • Intra-articular
  • Intraocular
  • Intrathecal
  • Intravenous
  • Ophthalmic
  • Oral
  • Parenteral
  • Subcutaneous
  • Topical
  • Transdermal

By Molecule Type

  • Oligonucleotide
  • Peptide
  • Small molecule

Scope of the Epilepsy Report

Coverage: Global

Key Epilepsy Companies: Eisai Co.LTD., Alexza Pharmaceuticals, Xenon Pharmaceuticals (NASDAQ: XENE), GW Pharmaceuticals, Equilibre Biopharmaceuticals, Takeda Pharmaceuticals, Abide therapeutics, Otsuka pharmaceutical, and others

Key Epilepsy Pipeline Therapies: Perampanel, Alprazolam, XEN1101, GWP42006, EQU-001, TAK-935, Lu AG06466, OPC-214870, and others

Table of Contents

1. Epilepsy Pipeline Report Introduction
2. Epilepsy Pipeline Report Executive Summary
3. Epilepsy Pipeline: Overview
4. Analytical Perspective In-depth Commercial Assessment
5. Epilepsy Pipeline Therapeutics
6. Epilepsy Pipeline: Late Stage Products (Pre-registration)
7. Epilepsy Pipeline: Late Stage Products (Phase III)
8. Epilepsy Pipeline: Mid Stage Products (Phase II)
9. Epilepsy Pipeline: Early Stage Products (Phase I)
10. Epilepsy Pipeline Therapeutic Assessment
11. Inactive Products in the Epilepsy Pipeline
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Key Companies
14. Key Products in the Epilepsy Pipeline
15. Unmet Needs
16. Market Drivers and Barriers
17. Future Perspectives and Conclusion
18. Analyst Views
19. Appendix

Got queries? Reach out for more information @ Epilepsy Pipeline Assessment

Related Reports

Epilepsy Market

Epilepsy Market Insights, Epidemiology, and Market Forecast-2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key epilepsy companies including Takeda Pharmaceuticals, Abide therapeutics, Otsuka pharmaceutical, among others.

Epilepsy Epidemiology Forecast

Epilepsy Epidemiology Forecast to 2032 report delivers an in-depth understanding of the disease, historical and forecasted epilepsy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Refractory Epilepsy Pipeline

Refractory Epilepsy Pipeline Insight, 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key refractory epilepsy companies, including Eisai Co.LTD., Alexza Pharmaceuticals, Xenon Pharmaceuticals, among others.

Partial Epilepsy Pipeline

Partial Epilepsy Pipeline Insight, 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key partial epilepsy companies, including GW Pharmaceuticals, Equilibre Biopharmaceuticals, among others.

Refractory Epilepsy Market

Refractory Epilepsy Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key refractory epilepsy companies including Eisai Co.LTD., Alexza Pharmaceuticals, Xenon Pharmaceuticals, among others.

Partial Epilepsy Market

Partial Epilepsy Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key partial epilepsy companies, including GW Pharmaceuticals, Equilibre Biopharmaceuticals, among others.

Other Trending Reports

Atopic Dermatitis Market | Peripheral Vascular Devices Market | Obsessive-Compulsive Disorder Market | Sinus Dilation Devices Market | Papilloma Market | Germ Cell Tumor Market | Portal Hypertension Market | Cell And Gene Therapy For Multiple Myeloma Market | Fallopian Tube Cancer Market | Atherectomy Devices Market | Oncolytic Virus Cancer Therapy Market | Urinary Incontinence Market | Cholangiocarcinoma Market | Tissue Heart Valves/Cardiovascular Prosthetic Devices Market | Artificial Disc Market | Obesity Market | Cerebral Infarction Market | Hematuria Market | Diabetes Market | Spinal Fusion Devices Market | Panuveitis Market | Prosthetic Heart Valve Market

Latest Healthcare Blogs

  • Generalized Myasthenia Gravis Treatment Outlook
  • ADPKD Market Scenario
  • Leading Neurostimulation Devices for Pain Management
  • Bronchopulmonary Dysplasia Treatment Market
  • RVO Market Beyond Lucentis and Eylea
  • Role of Nanobots in Healthcare
  • Wilson’s Disease Pipeline Therapies
  • denovoSkin – Personalized Skin Grafts for Burn Treatment

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  

Contact Us

Sandeep Joshi 

info@delveinsight.com 

+1(919)321-6187

www.delveinsight.com

Sign up and submit a press release

Sponsored
C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email